Here’s whether Merck & Co., Inc. (MRK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.43% over 10 days); RSI 58 — healthy momentum range; strong 1-year return of +55.8%; 3-month momentum positive (+17.1%). Currently 0.5% off its 52-week high. Score: +7/7.
MRK is in a confirmed uptrend, trading above both its 50-day ($121.10) and 200-day ($110.49) moving averages. An RSI of 57.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +55.8% compares to +16.5% for SPY (beat the market by 39.4%).
$10,000 invested 1 year ago→ $15,583 today
vs. S&P 500 (SPY) — same period beat market by 39.4%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($110.49)
✓Above 50-day MA ($121.10)
✓RSI(14) neutral zone (30–70) — currently 57.7
✓Positive return (+55.8%)
✓Within 10% of period high (−0.5%)
Period Range $131.07
$76.66$131.74
RSI (14) 57.7
0 · OversoldOverbought · 100
Key Metrics
Price$131.07
Period Return+55.8%
Period High$131.74
Period Low$76.66
Drawdown−0.5%
MA-50$121.10
MA-200$110.49
RSI (14)57.7
Avg Volume (30d)10.9M
vs. SPYbeat by 39.4%
Return Rank#191 of 999
Trend Signals
Price is above the 200-day moving average ($110.49)
Price is above the 50-day moving average ($121.10)